President Donald Trump is launching a project that aims to fast-track the development of a coronavirus vaccine. Called “Operation Warp Speed,” its goal is to manufacture millions of doses of the vaccine by the end of the year, according to CNN.
“I hope we’re going to have a vaccine and we’re going to fast-track a vaccine like you’ve never seen before if we come with a vaccine,” Donald Trump said during a meeting with New Jersey Gov. Phil Murphy at the White House, CNBC reported. “I think they probably will.”
The project’s goal might appear a bit optimistic but Trump is confident that it can be done. “I’m not overpromising,” he said. “Whatever the maximum is, whatever you can humanly do, we’re going to do.”
Trump also said that he will personally oversee the project. “I’m really in charge of it,” the POTUS said. “I think probably more than anything I’m in charge.”
There are multiple projects all over the world working on creating a coronavirus vaccine but it might take some time before their efforts bear fruit. According to the National Institute of Allergy and Infectious Diseases director Dr. Anthony Fauci, a vaccine for the virus might take between a year and 18 months to develop.
However, Donald Trump said that in Operation Warp Speed, both government researchers and pharmaceutical firms will join forces to shorten the development time of the vaccine, a cooperation that has been described as a Manhattan Project-like effort. The Manhattan Project was a World War II led by the U.S. with support from the U.K. Canada to develop the first atomic bomb and end the war.
The U.S. has the highest number of COVID-19 cases worldwide with more than 1.1 million Americans infected with the virus, according to data from Worldometers. The country also has the highest number of casualties with more than 67,000 deaths due to the disease.
One positive development in the country’s fight against the pandemic is that Gilead Sciences’ antiviral drug remdesivir showed positive outcomes in initial trials. COVID-19 patients who took the drug recovered 30 percent faster than those who took a placebo.


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
US Pushes Ukraine-Russia Peace Talks Before Summer Amid Escalating Attacks
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Bangladesh Election 2026: A Turning Point After Years of Political Suppression
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Federal Judge Restores Funding for Gateway Rail Tunnel Project
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
Ghislaine Maxwell to Invoke Fifth Amendment at House Oversight Committee Deposition
Bosnian Serb Presidential Rerun Confirms Victory for Dodik Ally Amid Allegations of Irregularities
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 



